Education
About Us
Working with TipRanks
Follow Us
Brainsway Ltd (BRSYF)
OTHER OTC:BRSYF
BRSYF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.10 - $8.53
Previous CloseN/A
Volume2.42K
Average Volume (3M)3.00
Market Cap
$226.24M
Enterprise Value$391.79M
Total Cash (Recent Filing)$71.60M
Total Debt (Recent Filing)$5.57M
Price to Earnings (P/E)55.2
Beta-0.56
Next Earnings
Aug 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding37,800,600
10 Day Avg. Volume0
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.73
Enterprise Value/Revenue9.02
Enterprise Value/Gross Profit12.10
Enterprise Value/Ebitda64.48
Forecast
1Y Price Target
$6.70Price Target Upside12.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Brainsway News
BRSYF FAQ
What was Brainsway Ltd’s price range in the past 12 months?
Brainsway Ltd lowest stock price was $2.10 and its highest was $8.53 in the past 12 months.
What is Brainsway Ltd’s market cap?
Brainsway Ltd’s market cap is $226.24M.
When is Brainsway Ltd’s upcoming earnings report date?
Brainsway Ltd’s upcoming earnings report date is Aug 13, 2025 which is today.
How were Brainsway Ltd’s earnings last quarter?
Brainsway Ltd released its earnings results on May 13, 2025. The company reported $0.031 earnings per share for the quarter, beating the consensus estimate of N/A by $0.031.
Is Brainsway Ltd overvalued?
According to Wall Street analysts Brainsway Ltd’s price is currently Undervalued.
Does Brainsway Ltd pay dividends?
Brainsway Ltd does not currently pay dividends.
What is Brainsway Ltd’s EPS estimate?
Brainsway Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brainsway Ltd have?
Brainsway Ltd has 37,800,600 shares outstanding.
What happened to Brainsway Ltd’s price movement after its last earnings report?
Brainsway Ltd reported an EPS of $0.031 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Brainsway Ltd?
Currently, no hedge funds are holding shares in BRSYF
Company Description
Brainsway Ltd
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
BRSYF Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
BrainsWay's earnings call highlighted strong revenue growth and an increase in system shipments, alongside advancements in clinical trials and positive cash flow. However, these positives were countered by increased operating expenses and ongoing monitoring of geopolitical and tariff risks.View all BRSYF earnings summariesBRSYF Stock 12 Month Forecast
Average Price Target
$6.70
▲(12.04% Upside)
Technical Analysis
Ownership Overview
―
Insiders
0.35% Mutual Funds
0.24% Other Institutional Investors
99.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---